Is Ketamine Efficacious for Rapid Treatment of Acute Suicidal Ideation in an Emergency Setting? Lessons Learned from A Pilot Randomized Controlled Trial
Open accessPreprint — published as 10.1186/s13104-024-07029-7 · Paper page
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background Ketamine has emerged as a promising agent for the rapid reduction of suicidal thoughts. However, its efficacy across a broader spectrum of psychiatric disorders remains underexplored.Objective This study aimed to evaluate the efficacy of a single infusion of ketamine in inducing rapid remission of severe suicidal ideation, compared to Midazolam, in a population with acute suicidal thoughts.Methods In a double-blind randomized controlled trial conducted in Tehran, Iran, from January to July 2022 (IRCT20220118053756N1), 36 inpatients with acute severe suicidal ideation were enrolled. Participants were randomly assigned to receive either a single dose of ketamine (0.5 mg/kg) or Midazolam (0.02 mg/kg). Suicidality was assessed using the Beck Scale for Suicide Ideation (BSSI) and the Suicide-Visual Analog Scale (S-VAS) before the intervention and at 12 and 24 hours post-administration.Results At baseline, the Midazolam group exhibited significantly higher BSSI scores and a higher rate of borderline personality disorder than the Ketamine group. Mean BSSI and S-VAS scores at 12 and 24 hours after the treatment in both groups. Despite these observations, no statistically significant differences were found between the groups in terms of BSSI and S-VAS scores.Conclusions The findings suggest that ketamine may reduce suicidal ideation, but its efficacy varies by psychiatric diagnosis. The groups were not significantly different in the main study outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Research works printed but not linked: 16
- Kastrup MC. Health Coverage and Mental Illness: The Ongoing Issue of Mental Health Gap (mhGAP). Indian J Social Psychiatry. 2016;32(3):251–3. · DOI
- Weber AN, Michail M, Thompson A, Fiedorowicz JG. Psychiatric emergencies: assessing and managing suicidal ideation. Med Clin. 2017;101(3):553–71.
- Caddy C, Giaroli G, White TP, Shergill SS, Tracy DK. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. Therapeutic Adv Psychopharmacol. 2014;4(2):75–99. · DOI · Paper page
- Ballard ED, Fields J, Farmer CA, Zarate CA Jr. Clinical trials for rapid changes in suicidal ideation: Lessons from ketamine. Suicide Life-Threatening Behav. 2021;51(1):27–35. · DOI · Paper page
- Siegel AN, Di Vincenzo JD, Brietzke E, Gill H, Rodrigues NB, Lui LM, et al. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review. J Psychiatr Res. 2021;137:426–36. · DOI · Paper page
- Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, et al. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. Am J Psychiatry. 2018;175(2):150–8. · DOI · Paper page
- Witt K, Potts J, Hubers A, Grunebaum MF, Murrough JW, Loo C, et al. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials. Australian New Z J Psychiatry. 2019;54(1):29–45. · DOI · Paper page
- Ahmadpanah M, Sheikhbabaei M, Haghighi M, Roham F, Jahangard L, Akhondi A, et al. Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale. Neuropsychiatr Dis Treat. 2016;12:603–7.
- Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight? Am J Psychiatry. 2004;161(12):2163–77. · DOI · Paper page
- Esfahani M, Hashemi Y, Alavi K. Psychometric assessment of Beck scale for suicidal ideation (BSSI) in general population in Tehran. MJIRI. 2015;29(1):862–71.
- Abbar M, Demattei C, El-Hage W, Llorca P-M, Samalin L, Demaricourt P et al. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial. BMJ. 2022;376.
- Grunebaum MF, Galfalvy HC, Choo TH, Keilp JG, Moitra VK, Parris MS, et al. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial. Am J Psychiatry. 2018;175(4):327–35. · DOI · Paper page
- Domany Y, Shelton RC, McCullumsmith CB. Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo‐controlled, proof‐of‐concept trial. Depress Anxiety. 2020;37(3):224–33. · DOI · Paper page
- Chen KS, Dwivedi Y, Shelton RC. The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder. J Affect Disord. 2022;315:13–6. · DOI
- LINKS PS, Boggild A, Sarin N. Modeling the relationship between affective lability, impulsivity, and suicidal behavior in patients with borderline personality disorder. J Psychiatric Practice®. 2000;6(5):247–55. · DOI
- Rizk MM, Choo T-H, Galfalvy H, Biggs E, Brodsky BS, Oquendo MA, et al. Variability in suicidal ideation is associated with affective instability in suicide attempters with borderline personality disorder. Psychiatry. 2019;82(2):173–8. · DOI · Paper page
Metadata
- Authors
- Barzkar, M., Alavi, K., Malakouti, K., Khajeh-Azad, M.-A., Barzkar, F., Jalali-Nadoushan, A., & Lahiji, M. N.
- Affiliations
- Iran University of Medical Sciences (IR)
- Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran,
- Venue
- BMC Research Notes
- Published
- 2024-08-11
- Volume
- 18
- Issue
- 1
- Pages
- 65-65
- ISSN
- 1756-0500 (ISSN-L)
- PMC
- PMC11823077
- OpenAlex
- W4407423713
- Cited by
- 1
- References
- 1
- Citations by year
- 2026: 1
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Research Notes (publishedVersion, cc-by-nc-nd)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- ketamine, suicidal ideation, midazolam, rapid remission, borderline personality disorder, suicide risk, single-dose infusion, Beck Scale for Suicide Ideation
- MeSH terms
- Adult, Double-Blind Method, Emergency Service, Hospital, Female, Humans, Iran, Ketamine, Male, Midazolam, Middle Aged, Pilot Projects, Treatment Outcome, Young Adult, Suicidal Ideation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is Ketamine Efficacious for Rapid Treatment of Acute Suicidal Ideation in an Emergency Setting? Lessons Learned from A Pilot Randomized Controlled Trial. https://app.cochat.ai/papers/10.21203/rs.3.rs-4718815/v1
- The paper
- Barzkar, M., Alavi, K., Malakouti, K., Khajeh-Azad, M.-A., Barzkar, F., Jalali-Nadoushan, A., & Lahiji, M. N. (2024). Is Ketamine Efficacious for Rapid Treatment of Acute Suicidal Ideation in an Emergency Setting? Lessons Learned from A Pilot Randomized Controlled Trial. BMC Research Notes. https://doi.org/10.21203/rs.3.rs-4718815/v1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
